HighTower Advisors LLC Buys 5,000 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

HighTower Advisors LLC boosted its stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 13.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,400 shares of the company’s stock after acquiring an additional 5,000 shares during the period. HighTower Advisors LLC owned 0.09% of KORU Medical Systems worth $167,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Empire Financial Management Company LLC purchased a new stake in KORU Medical Systems in the 3rd quarter worth about $259,000. Calamos Advisors LLC bought a new position in KORU Medical Systems during the fourth quarter worth about $250,000. White Pine Capital LLC increased its stake in shares of KORU Medical Systems by 25.6% in the fourth quarter. White Pine Capital LLC now owns 157,917 shares of the company’s stock worth $608,000 after purchasing an additional 32,176 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of KORU Medical Systems in the fourth quarter valued at approximately $118,000. Finally, Geode Capital Management LLC lifted its stake in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after buying an additional 28,323 shares in the last quarter. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $2.28 on Friday. The business has a 50-day simple moving average of $3.53 and a 200 day simple moving average of $3.41. KORU Medical Systems, Inc. has a 52 week low of $2.05 and a 52 week high of $5.05. The stock has a market cap of $104.78 million, a price-to-earnings ratio of -9.12 and a beta of 0.87. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on KRMD. B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. Craig Hallum lifted their price target on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, January 17th. Piper Sandler restated a “neutral” rating and issued a $4.50 target price on shares of KORU Medical Systems in a research note on Friday, February 14th. Finally, Lake Street Capital upped their price target on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $4.70.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.